BIOMAT Database Logo BIOMAT Database Logo

[Evaluation of antibacterial activities of various antibiotics against glucose non-fermentative gram-negative rods other than Pseudomonas aeruginosa]. 1998

M Kouda, and J Fukuhara, and M Takeuchi, and M Ohgawara, and H Matsuzaki, and H Tohi, and N Furuhata, and M Maruyama, and K Sasaki, and E Sawabe, and A Ikeda, and T Suzuki, and H Satoh, and I Takahashi, and F Kimura, and H Nomura, and E Ono
First Division of Clinical Laboratories, Tokyo Metropolitan Police Hospital.

MICs of piperacillin, sulbactam/cefoperazone, minocycline (MINO), gentamicin, amikacin, flomoxef, ceftazidime, cefozopran, cefsulodin and imipenem were determined, against 189 clinical isolated strains of glucose non-fermentative Gram-negative Rods (NFGNR; Acinetobacter baumannii (44), Alcaligenes faecalis (5), Alcaligenes xylosoxidans (25), Burkholderia cepacia (12), Chryseobacterium indologenes (23), Chryseobacterium meningosepticum (9), Pseudomonas fluorescens (8), Pseudomonas putida (12), Stenotrophomonas maltophilia (51). Most species of these NFGNR show resistance to many antibiotics tested. Among the antibiotics used in this study, the only antibiotic effective against all species of NFGNR tested is MINO. The spectrums of antibacterial activities of various antibiotics determined by MICs may be useful in preliminary test for identification of these NFGNR.

UI MeSH Term Description Entries
D008911 Minocycline A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections. Akamin,Akne-Puren,Aknemin,Aknin-Mino,Aknosan,Apo-Minocycline,Arestin,Blemix,Cyclomin,Cyclops,Dentomycin,Dynacin,Icht-Oral,Klinomycin,Lederderm,Mestacine,Minakne,Mino-Wolff,Minocin,Minocin MR,Minoclir,Minocycline Hydrochloride,Minocycline Monohydrochloride,Minocycline, (4R-(4 alpha,4a beta,5a beta,12a beta))-Isomer,Minolis,Minomycin,Minoplus,Minotab,Minox 50,Mynocine,Akne Puren,Aknin Mino,Apo Minocycline,Hydrochloride, Minocycline,Icht Oral,Mino Wolff,Monohydrochloride, Minocycline
D010403 Penicillin Resistance Nonsusceptibility of an organism to the action of penicillins. Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D010878 Piperacillin Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics. AB-Piperacillin,Cl-227193,Pipcil,Pipera-Hameln,Piperacillin Curasan,Piperacillin Fresenius,Piperacillin Hexal,Piperacillin Monosodium Salt,Piperacillin Sodium,Piperacillin-Ratiopharm,Pipercillin,Pipracil,Pipril,T-1220,T1220,AB Piperacillin,Cl 227193,Cl227193,Curasan, Piperacillin,Monosodium Salt, Piperacillin,Pipera Hameln,Piperacillin Ratiopharm,Salt, Piperacillin Monosodium,Sodium, Piperacillin,T 1220
D002438 Cefoperazone Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It may be used to treat Pseudomonas infections. Cefobid,Cefoperazon,Cefoperazone Sodium,Cefoperazone Sodium Salt,Céfobis,T-1551,T1551,Salt, Cefoperazone Sodium,Sodium Salt, Cefoperazone,Sodium, Cefoperazone,T 1551
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Kouda, and J Fukuhara, and M Takeuchi, and M Ohgawara, and H Matsuzaki, and H Tohi, and N Furuhata, and M Maruyama, and K Sasaki, and E Sawabe, and A Ikeda, and T Suzuki, and H Satoh, and I Takahashi, and F Kimura, and H Nomura, and E Ono
[Antibacterial activities of combination uses of cefpirome with various antibiotics in vitro against clinically isolated glucose non-fermentative gram-negative rods: part 1. the results against Pseudomonas aeruginosa].
January 1996, The Japanese journal of antibiotics,
M Kouda, and J Fukuhara, and M Takeuchi, and M Ohgawara, and H Matsuzaki, and H Tohi, and N Furuhata, and M Maruyama, and K Sasaki, and E Sawabe, and A Ikeda, and T Suzuki, and H Satoh, and I Takahashi, and F Kimura, and H Nomura, and E Ono
Bacteraemia in adults due to glucose non-fermentative Gram-negative bacilli other than P. aeruginosa.
March 2003, QJM : monthly journal of the Association of Physicians,
M Kouda, and J Fukuhara, and M Takeuchi, and M Ohgawara, and H Matsuzaki, and H Tohi, and N Furuhata, and M Maruyama, and K Sasaki, and E Sawabe, and A Ikeda, and T Suzuki, and H Satoh, and I Takahashi, and F Kimura, and H Nomura, and E Ono
Septicaemia due to glucose non-fermenting, gram-negative bacilli other than Pseudomonas aeruginosa in children.
January 2002, Acta paediatrica (Oslo, Norway : 1992),
M Kouda, and J Fukuhara, and M Takeuchi, and M Ohgawara, and H Matsuzaki, and H Tohi, and N Furuhata, and M Maruyama, and K Sasaki, and E Sawabe, and A Ikeda, and T Suzuki, and H Satoh, and I Takahashi, and F Kimura, and H Nomura, and E Ono
[Susceptibilities of glucose non-fermentative gram-negative bacilli to antibiotics].
August 1994, The Japanese journal of antibiotics,
M Kouda, and J Fukuhara, and M Takeuchi, and M Ohgawara, and H Matsuzaki, and H Tohi, and N Furuhata, and M Maruyama, and K Sasaki, and E Sawabe, and A Ikeda, and T Suzuki, and H Satoh, and I Takahashi, and F Kimura, and H Nomura, and E Ono
[Frequency of clinical isolation of glucose non-fermentative gram-negative rods and their susceptibilities to antibacterial agents].
September 1995, The Japanese journal of antibiotics,
M Kouda, and J Fukuhara, and M Takeuchi, and M Ohgawara, and H Matsuzaki, and H Tohi, and N Furuhata, and M Maruyama, and K Sasaki, and E Sawabe, and A Ikeda, and T Suzuki, and H Satoh, and I Takahashi, and F Kimura, and H Nomura, and E Ono
[Three cases of septicemia caused by glucose non-fermentative gram-negative rods].
May 1985, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
M Kouda, and J Fukuhara, and M Takeuchi, and M Ohgawara, and H Matsuzaki, and H Tohi, and N Furuhata, and M Maruyama, and K Sasaki, and E Sawabe, and A Ikeda, and T Suzuki, and H Satoh, and I Takahashi, and F Kimura, and H Nomura, and E Ono
Survey on antibiotic resistance in gram-negative non-fermentative bacteria other than pseudomonas in Italy.
February 1994, Journal of chemotherapy (Florence, Italy),
M Kouda, and J Fukuhara, and M Takeuchi, and M Ohgawara, and H Matsuzaki, and H Tohi, and N Furuhata, and M Maruyama, and K Sasaki, and E Sawabe, and A Ikeda, and T Suzuki, and H Satoh, and I Takahashi, and F Kimura, and H Nomura, and E Ono
Antibacterial Activity of Non-Cytotoxic, Amino Acid-Modified Polycationic Dendrimers against Pseudomonas aeruginosa and Other Non-Fermenting Gram-Negative Bacteria.
August 2020, Polymers,
M Kouda, and J Fukuhara, and M Takeuchi, and M Ohgawara, and H Matsuzaki, and H Tohi, and N Furuhata, and M Maruyama, and K Sasaki, and E Sawabe, and A Ikeda, and T Suzuki, and H Satoh, and I Takahashi, and F Kimura, and H Nomura, and E Ono
Comparative antibacterial activities of new beta-lactam antibiotics against Pseudomonas aeruginosa.
January 1985, Chemotherapy,
M Kouda, and J Fukuhara, and M Takeuchi, and M Ohgawara, and H Matsuzaki, and H Tohi, and N Furuhata, and M Maruyama, and K Sasaki, and E Sawabe, and A Ikeda, and T Suzuki, and H Satoh, and I Takahashi, and F Kimura, and H Nomura, and E Ono
[Gram-negative rods: antibacterial agents effective on gram-negative rods].
February 1994, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!